Garth Monroe joins BioNano Genomics as CFO
This article was originally published in Clinica
Executive Summary
BioNano Genomics, a company working to increase understanding of genomes, has hired Garth Monroe as chief financial officer. Mr Monroe joins the company's senior management team and will report to president and CEO Dr R Erik Holmlin. Prior to his appointment at BioNano Genomics, Mr Monroe served as CFO for Epocal, a multinational medical device company.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.